BioSpace News Archive

According to the report, the global bioremediation technology & services market was valued at ~US$ 9 Bn in 2019.

Most drug addicts find it difficult to wean themselves away from the fatal substance and require a protracted therapy for that.

Biomerica Inc. announced that it has filed a new three year shelf registration statement on Form S-3 with the United States Securities and Exchange Commission to replace its previous three year shelf registration statement, which was declared effective by the SEC in July 2017.

Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless devices, announced it will release financial results for the second quarter ended June 30, 2020, after market close on Wednesday, August 5, 2020.

Generation Bio Co . (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, today announced that Matthew Norkunas, M.D., MBA, has been appointed chief financial officer. “We are delighted to add Matt’s broad strategic perspective and deep operational experience to our team as we prepare the platform for our journey to the clinic,” said Geoff McDonough, M.D., president and chief executive of

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced that its phase 3 pivotal RECONSM Clinical Study supporting its Biologics License Application (BLA) submission for Avance Nerve Graft has reached its enrollment target of 220 subjects

Replimune Group, Inc. (Nasdaq: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic™ platform, today announced the strengthening of its executive team with the appointment of Andrea Pirzkall, M.D. as Replimune’s Chief Medical Officer effective August 31 st , 2020. “We are very excited to have Andrea join the Replimune team as we aggressively advance our pipeline,” said Philip Astley-Sparke, Chief

Patient access expansion is a result of updated medical necessity guidelines by National Imaging Associates, a Magellan Health Company.

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), will hold a conference call and webcast to discuss its second quarter 2020 operating results on Wednesday, August 5, 2020 at 8 a.m. EDT . The conference call will be hosted by TRHC CEO, Chairman and Founder, Calvin H. Knowlton, Ph.D.; TRHC Co-Founder, President, Chief Marketing and Business Development Officer, Orsula V. Knowlton, PharmD; and TRHC Chief Financial Officer, Brian W. Adams. The Com

HealthWell Appoints Cathleen D. Bennett, Esquire as Director.